Supreme Court Denies Ferring B.V.'s Petition

Law360, New York (November 1, 2006, 12:00 AM EST) -- The U.S. Supreme Court has refused to hear an appeal from Dutch drug maker Ferring B.V., dashing its hopes for restoring a patent for a rare hormone deficiency treatment and raising concerns that inequitable conduct rules will be abused to invalidate patents.

“The problem isn’t going to go away and the Supreme Court will have to address it eventually,” said Richard Samp, chief counsel for the Washington Legal Institute, which filed an amicus brief in support of the appeal.

The decision could also add more time...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.